Clinical Trial Update: Metabolic and Vascular Effects of Statins in Untreated Dyslipidemic Diabetic Patients [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the metabolic and vascular effects of statins in untreated patients with Type 2 diabetes and diabetic dyslipidemia; the trial has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Statins

Snippet

Sponsor: University of Rome Tor Vergata | Conditions: Type 2 Diabetes, Diabetic Dyslipidemia | Phase 3 | Status: COMPLETED